PROGRAMMED CELL DEATH
HISTOLOGICAL CHARACTERIZATION AND PHARMACOLOGICAL CONTROL OF CHRONIC REJECTION IN XENOGENEIC AND ALLOGENEIC HEART TRANSPLANTATION1
PROTECTION AGAINST ALLOGRAFT REJECTION WITH INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES1
EXPRESSION OF TISSUE FACTOR IN HEPATIC ISCHEMIC-REPERFUSION INJURY OF THE RAT
COMPLEMENT INHIBITION BY SOLUBLE COMPLEMENT RECEPTOR TYPE 1 IMPROVES MICROCIRCULATION AFTER RAT LIVER TRANSPLANTATION1,2
EFFECT OF COMPLEMENT INHIBITION WITH SOLUBLE COMPLEMENT RECEPTOR 1 ON PIG ALLOTRANSPLANT LUNG FUNCTION1
TREATMENT OF CHRONIC HEPATITIS B WITH LAMIVUDINE IN RENAL TRANSPLANT RECIPIENTS1
BACKGROUND AND PROGNOSTIC IMPLICATIONS OF PERIREPERFUSION TISSUE INJURIES IN HUMAN LIVER TRANSPLANTS
ANTI-GAL ANTIBODY-MEDIATED ALLOGRAFT REJECTION IN α1,3-GALACTOSYLTRANSFERASE GENE KNOCKOUT MICE
A MURINE MODEL OF ANTIBODY-MEDIATED HYPERACUTE REJECTION BY GALACTOSE-α(1,3)GALACTOSE ANTIBODIES IN Gal o/o MICE1
T-CELL AND MAJOR HISTOCOMPATIBILITY COMPLEX REQUIREMENTS FOR OBLITERATIVE AIRWAY DISEASE IN HETEROTOPICALLY TRANSPLANTED MURINE TRACHEAS1
SUCCESSFUL NERVE REGENERATION AND PERSISTENCE OF DONOR CELLS AFTER A LIMITED COURSE OF IMMUNOSUPPRESSION IN RAT PERIPHERAL NERVE ALLOGRAFTS
DOWN-MODULATION OF HOST REACTIVITY BY ANTI-CD44 IN SKIN TRANSPLANTATION1
ACCESSORY RIGHT HEPATIC ARTERY ARISING FROM THE LEFT
HEMOPHAGOCYTOSIS: A POTENTIAL COMPLICATION IN SMALL BOWEL TRANSPLANTATION
TUBULAR ANTITHROMBIN AT TRANSPLANTATION DETERMINES SUBSEQUENT RENAL ALLOGRAFT FUNCTION1,2
POSTTRANSPLANT THERAPY USING HIGH-DOSE HUMAN IMMUNOGLOBULIN (INTRAVENOUS GAMMAGLOBULIN) TO CONTROL ACUTE HUMORAL REJECTION IN RENAL AND CARDIAC ALLOGRAFT RECIPIENTS AND POTENTIAL MECHANISM OF ACTION1
DISTRIBUTION OF ENDOTHELIN-1 IN TRANSPLANTED HUMAN LUNGS1
CREATION OF THE "THYMOHEART" ALLOGRAFT
Announcements
ERRATUM